AGP Executive Report
Last update: 10 hours agoLife Sciences & Space Manufacturing: Worcester nanomedicine startup Eascra Biotech won a $7.96M NASA contract to develop lipid-based drug delivery materials using low-orbit microgravity manufacturing, aiming for more stable, uniform products for RNA therapeutics and harder-to-reach tissues. Biotech in Boston: Boston Medical Center and BU researchers reported a scalable method to generate CD4+ helper T cells from iPSCs, a step toward off-the-shelf CAR-T therapies. Cell Therapy Scale-Up: Watertown’s Oryon Cell Therapies appointed Kenny Choi as CTO to lead CMC strategy and transfer its iPSC-derived dopaminergic neuron manufacturing from MGB to its own facilities. Cybersecurity & Medical Devices: Boston Scientific said a cyberattack disrupted systems used to process and ship device orders, with knock-on staffing and logistics issues reported at its Cork operations. Massachusetts Policy: The new PROTECT Act requires employers to notify staff within 48 hours of an ICE inspection notice, effective immediately. Research Funding & Talent Migration: Multiple Massachusetts researchers are among dozens relocating to Canada after federal funding commitments, including a McGill move for UMass Chan’s Phillip Zamore. AI & Business: A new analysis argues “AI agents” are breaking traditional per-seat SaaS pricing, pushing software toward usage-based models. Meta Settlement: Virginia is set to receive $353M under a multistate Meta teen-safety settlement that also mandates new safeguards for Instagram and Facebook.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.